FIRST AMENDMENT TO SUBLEASE AGREEMENTSublease Agreement • June 8th, 2018 • Magenta Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJune 8th, 2018 Company IndustryTHIS FIRST AMENDMENT TO SUBLEASE AGREEMENT (this “Amendment”) is made as of May 30, 2018, by and between SURFACE ONCOLOGY, INC., a Delaware corporation, having an office at 50 Hampshire Street, Cambridge, MA 02139 (“Sublandlord”), and MAGENTA THERAPEUTICS, INC., a Delaware corporation, having an office at 50 Hampshire Street, Cambridge, MA 02139 (the “Subtenant”).